BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves
Authors (first, second and last of 7)
Collection
COVID-19
The ongoing global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused hundreds of millions of infections, and millions of deaths have been attributed to the disease. Publishing research on Covid-19 is crucial to understand how it affects patients, to combat the disease, and to ultimately overcome this global health emergency.
The Journal of Neurology has dedicated an article collection to neurological research in connection to Covid-19. This article collection aims to gather all articles relevant to neurological disease and Covid-19 in one place, so that researchers and clinicians can easily access reviews, original articles, short commentaries and case reports on the subject.
The article collection on Covid-19 will remain open; manuscripts on Covid-19 can be submitted freely to the journal and will be added to the collection upon publication. Submissions on Covid-19 are subject to the rigorous peer review the journal conducts for all unsolicited manuscripts. Peer review of Covid-19 manuscripts is steered by Massimo Filippi, one of the Chief Editors of Journal of Neurology. A related collection in the journal features articles on Long COVID-19 Syndrome.
Editors
-
Massimo Filippi
Massimo Filippi is Full Professor of Neurology at Università Vita-Salute San Raffaele, Milan, Italy; Director Residency School in Neurology; Chair of the Neurology Unit, Neurorehabilitation Unit and Neurophysiology Service and Director of the Neuroimaging Research Unit, Department of Neurology, IRCCS Ospedale San Raffaele, Milan. His research focuses on the definition of the mechanisms leading to progressive accumulation of irreversible physical disability and cognitive impairment in various neurological conditions. He is Chief Editor of the Journal of Neurology and responsible for the article collection on Covid-19.
Articles (206 in this collection)
-
-
Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors
Authors (first, second and last of 7)
-
Status epilepticus during the COVID-19 pandemic in Cologne, Germany: data from a retrospective, multicentre registry
Authors (first, second and last of 7)
-
SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19
Authors (first, second and last of 6)
-
Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations
Authors (first, second and last of 13)
-
Anti-LGI1 encephalitis following COVID-19 vaccination: a case series
Authors (first, second and last of 18)
-
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature
Authors (first, second and last of 4)
-
-
Combined central and peripheral demyelination after COVID-19 vaccination
Authors (first, second and last of 7)
-
Hypoechogenicity of brainstem raphe in long-COVID syndrome–less common but independently associated with depressive symptoms: a cross-sectional study
Authors (first, second and last of 8)
-
Exploring trajectory recovery curves of post-COVID cognitive symptoms in previously hospitalized COVID-19 survivors: the LONG-COVID-EXP-CM multicenter study
Authors (first, second and last of 6)
-
Autonomic dysfunction in long-COVID syndrome: a neurophysiological and neurosonology study
Authors (first, second and last of 8)
-
Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
Authors (first, second and last of 15)
-
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study
Authors (first, second and last of 17)
-
-
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms
Authors (first, second and last of 13)
-
Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination
Authors (first, second and last of 8)
-
Cerebral venous sinus thrombosis in the setting of COVID-19 vaccination: a systematic review and meta-analysis
Authors (first, second and last of 10)
-
-
Long-term cognitive impairments following COVID-19: a possible impact of hypoxia
Authors (first, second and last of 8)
-
Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic
Authors (first, second and last of 33)
-
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study
Authors (first, second and last of 21)
-
Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosis
Authors (first, second and last of 8)
-
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod
Authors (first, second and last of 11)
-
-
Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies
Authors (first, second and last of 8)
-
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre
Authors (first, second and last of 24)
-
-
-
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies
Authors (first, second and last of 6)
-
Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19
Authors (first, second and last of 9)
-
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience
Authors (first, second and last of 19)
-
Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a retrospective monocentric study
Authors (first, second and last of 6)
-
-
Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions
Authors (first, second and last of 13)
-
Ischemic stroke associated with COVID-19: a systematic review and meta-analysis
Authors (first, second and last of 4)
-
The impact of the UK COVID-19 pandemic on patient-reported health outcomes after stroke: a retrospective sequential comparison
Authors (first, second and last of 11)
-
COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2
Authors (first, second and last of 9)
-
Case report: cerebral sinus vein thrombosis in two patients with AstraZeneca SARS-CoV-2 vaccination
Authors (first, second and last of 9)
-
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
Authors (first, second and last of 9)
-
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies
Authors (first, second and last of 6)
-
Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature
Authors (first, second and last of 5)
-
COVID-19 manifestations in people with Parkinson’s disease: a USA cohort
Authors (first, second and last of 17)
-
COVID-19 mRNA vaccination leading to CNS inflammation: a case series
Authors (first, second and last of 9)
-
SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature
Authors (first, second and last of 6)
-
-
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity
Authors (first, second and last of 19)
-
-
Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study
Authors (first, second and last of 6)
-
Decrease in intravenous thrombolysis and poor short-term functional prognosis for acute ischemic stroke during the COVID-19 pandemic
Authors (first, second and last of 10)
